| Result |
Filter:
|
|||||||||||||||||||||||
| ID | SEQUENCE | LENGTH | VIRUS | INHIBITION/ IC50 |
UNIT | TARGET | ASSAY | PMID | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVP0179 | CTLTTKLYC | 9 | NDV | 1 | μM | Virus entry | Antibody competition assay | |||||||||||||||||
| AVP1745 | EVSHPKVG | 8 | NDV | Medium | - | Neutralization sites | NDV neutralization assay | |||||||||||||||||
| AVP1746 | SGGSNRSP | 8 | NDV | Medium | - | Neutralization sites | NDV neutralization assay | |||||||||||||||||
| AVP1747 | WVTTSNQW | 8 | NDV | Medium | - | Neutralization sites | NDV neutralization assay | |||||||||||||||||
| AVP1773 | NASDMEIKKVNKKIEEYIKKIEEVEKKLEEVNKK | 34 | NDV | 90 | % | Virus entry | Plaque assay | |||||||||||||||||
| AVP1774 | VNKKIEEIDKKIEELNKKLEELEKKLEEVNKK | 32 | NDV | 90 | % | Virus entry | Plaque assay | |||||||||||||||||
| AVP1831 | SISNALNKLEESNRNLDKVNVKLT | 24 | NDV | 3.27 | μM | Fusion | Syncitia assay | |||||||||||||||||
| AVP1832 | KQNAANILRLKESIAATNEAVHEV | 24 | NDV | 22.5 | nM | Fusion | Syncitia assay | |||||||||||||||||
| AVP2020 | NILRLKESITATIEAVHEVTDGLS | 24 | NDV | 2 | μM | Fusion | Fusion assay | |||||||||||||||||
| AVP2023 | ALDKLEESNSKLDKVNVKLT | 20 | NDV | 2 | μM | Fusion | Fusion assay | |||||||||||||||||
| AVP2024 | ALDKAEESNSKLDKVNVKLT | 20 | NDV | 6 | μM | Fusion | Fusion assay | |||||||||||||||||
| AVP2025 | ALDKAEESNSKADKVNVKLT | 20 | NDV | 35 | μM | Fusion | Fusion assay | |||||||||||||||||
| AVP2026 | ALDKAEESNSKADKVNVKAT | 20 | NDV | No | NA | Fusion | Fusion assay | |||||||||||||||||
|
||||||||||||||||||||||||
 |
 |